Details for New Drug Application (NDA): 090031
✉ Email this page to a colleague
The generic ingredient in CEFPODOXIME PROXETIL is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
Summary for 090031
Tradename: | CEFPODOXIME PROXETIL |
Applicant: | Chartwell Rx |
Ingredient: | cefpodoxime proxetil |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 50MG BASE/5ML | ||||
Approval Date: | Jan 14, 2009 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 100MG BASE/5ML | ||||
Approval Date: | Jan 14, 2009 | TE: | RLD: | No |
Complete Access Available with Subscription